Observational Study of BMAC with Hip Arthroscopy for FAI and Labral Tears

This study is looking at how well a treatment called Bone Marrow Aspirate Concentrate (BMAC) works when combined with hip arthroscopy (a minimally invasive surgery) for people with hip problems. These problems include a torn acetabular labrum (the cartilage rim of your hip socket) and femoroacetabular impingement (FAI), which is when extra bone on your hip bones causes them to rub together. Researchers want to see if BMAC can help repair the damage and potentially slow down the development of osteoarthritis. You might be able to join if you are 18 or older and have symptoms like hip pain, clicking, or catching. The main goal is to track changes in your hip pain and function using surveys over several years. This is an observational study, meaning researchers are watching what happens to people who receive this treatment as part of their care, rather than assigning them to different treatment groups. The study aims to include 400 participants.

Study design
This is an observational study, meaning researchers will follow participants who receive BMAC during hip arthroscopy. It aims to include 400 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Your hip pain and function will be tracked using surveys at 3 months, 6 months, 12 months, and annually after your surgery.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT03909139

Use of BMAC With Hip Arthroscopy Treatment of FAI and Labral Tear

Recruiting
Not specifiedAges 18+Observational
Massachusetts General Hospital
~400 participants
Updated 2025-10-27 on ClinicalTrials.gov
What's tested:BMAC

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change iHOT--33 Surveys from preoperative to various postoperative timepoints
Measured over Baseline (pre-operative), 3 months, 6 months, 12 months, and annually thereafter
Acetabular Labrum Tear
Femoro Acetabular Impingement
Chondral Defect
Bone Marrow Aspirate Concentrate
Mesenchymal Stromal Cell
1 sites across 1 states
Massachusetts1
  • Scott D Martin, MD · PRINCIPAL_INVESTIGATOR · Massachusetts General Hospital

Opens a ready-to-send draft in your own email app — review before sending.

  • Change iHOT--33 Surveys from preoperative to various postoperative timepointsBaseline (pre-operative), 3 months, 6 months, 12 months, and annually thereafter

    Full Name of Outcome: International Hip Outcome Tool--33 Questions Purpose: Validated Hip Patient Reported Outcome Measurements (PROMs) to assess the patient's functional outcomes post-surgery. Scale of iHOT-33: Min: 0 Max: 100 No standardized scoring categories (i.e. excellent, good, fair, poor). Higher score indicates better hip functionally. No subscores or subscales